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Summary 
 
 Use of progesterone inserts (controlled 
interval drug release, CIDR) offers another 
option for synchronizing estrus and ovulation 
in replacement heifers and lactating dairy 
cows. Results indicate that heifers may be in-
seminated after detected estrus, at a fixed time 
(timed AI), or a combination of both. Concep-
tion rates exceed 50% in both scenarios. Prac-
tical applications of the CIDR in lactating 
cows have been used to resynchronize the re-
turn estrus of previously inseminated cows 
and as part of first-service AI-breeding proto-
cols. Use for resynchronization has no draw-
backs in previously inseminated cows, but 
may increase embryo survival during the first 
30- to 60-days of pregnancy. No increase in 
the heat-detection rates of open cows is gener-
ally achieved, and no differences in return 
conception rates are observed between treated 
and control cows. First-service applications of 
the progesterone insert have resulted in some 
positive and some negative effects on timed 
AI (TAI) conception rates. More research is 
warranted to determine if an identifiable sub-
population of cows can benefit from exposure 
of the progesterone insert before first AI. 
 
(Key words: heifers, cows, CIDR, Ovsynch, 
pregnancy rates.) 
 
Introduction 
 
 Because fertility of lactating dairy cows is 
poor and has decreased more than 50% since 
1970, improving fertility of lactating dairy 
cows is economically important to dairy pro-
ducers. A negative relationship exists between 
dry matter intake and circulating concentra-
tions of progesterone in lactating dairy cows. 
Lactating dairy cows have serum concentra-
tions of progesterone less than those in heif-
ers. Progesterone is important to fertility, as 
demonstrated by a positive correlation be-
tween serum progesterone before AI and sub-
sequent conception rate. Progesterone, in addi-
tion to use of gonadotropin releasing hormone 
(GnRH) and prostaglandin F2α (PGF2α), can 
be used to facilitate AI by synchronizing es-
trus and ovulation in heifers and lactating 
cows. Understanding the pharmacological im-
pact of progesterone supplementation on con-
ception rates may lead to a better understand-
ing of the physiological reasons for reduced 
fertility of lactating dairy cows. 
 
 Today, progesterone is applied in the form 
of an intravaginally placed insert containing 
1.38 g of progesterone and is marketed as an 
EAZI-BREED CIDR. This is the only proges-
terone product approved by the U.S. Food and 
Drug Administration for use in cattle. Its label 
indications include synchronization of estrus 
in suckled beef cows and replacement beef 
and dairy heifers, advancement of first post-
partum estrus in suckled beef cows, and ad-
vancement of first pubertal estrus in beef heif-
ers. For these applications, the insert is left in 
place for 7 days, with an injection of Lutalyse 
1 day before insert removal. Signs of estrus 
are then observed on days 1 to 3 after insert 
removal, and insemination occurs about 12 
hours after the first signs of estrus. 
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 Label indications for lactating dairy cows 
include synchronization of the return estrus 
for cows previously inseminated. The insert is 
applied 14 ± 1 days after insemination and the 
insert is removed 7 days later. Again, signs of 
estrus are observed on days 1 to 3 after insert 
removal, and insemination should occur about 
12 hours after detection of estrus. 
 
 The objective of this review is to provide a 
summary of several proven applications of 
progesterone in successful AI-breeding pro-
grams. Most of the programs discussed are 
considered to be extra label, however, their 
application goal is to synchronize estrus and 
ovulation before insemination, either based on 
signs of estrus or by appointment (fixed-time 
AI or TAI). 
 
Replacement Heifers 
 
Injecting PGF2α  at the end of a short-
duration (7 days) CIDR treatment allows es-
trus in nearly all females to be synchronized 
during a shorter treatment period. Administer-
ing progesterone for approximately 7 days al-
lows any female in estrus or metestrus at the 
outset to advance to the luteal phase before 
PGF2 α is administered. Expression of estrus is 
prevented in the remaining females that are in 
proestrus or late diestrus by the progesterone 
insert, and those in the luteal phase respond to 
the injection of PGF2 α. Therefore, the combi-
nation of both hormones shortens the overall 
period of treatment and generally allows nor-
mal fertility. 
 
The standard labeled indication protocol is 
illustrated in Figure 1 (Option A) in which 
heifers are inseminated after detection of es-
trus. Average occurrence of estrus is about 43 
± 3 hours after insert removal, if PGF2α is ad-
ministered 24 hours before insert removal, or 
49 ± 1 hours if the injection occurs at insert 
removal. Conception and pregnancy rates are 
shown for Options B and C. In Option B, heif-
ers were treated at 3 locations in Kansas. In 
Option C, heifers were treated at 12 locations 
in the 6 Midwest states. Combining heat de-
tection to 84 hours after insert removal and a 
cleanup TAI at 84 hours resulted in 85% of 
the inseminations made before the cleanup 
TAI. The latter two treatments administered 
one TAI at 60 hours.  Note that measures of 
fertility are quite similar and administering 
GnRH upfront resulted in very little increase 
in fertility. The most consistent results at all 
12 locations in Option C, however, was the 
last treatment, in which GnRH was adminis-
tered upfront with the insert and one TAI was 
administered at 60 hours after insert removal. 
 
Lactating Dairy Cows 
 
Synchronizing Return to Estrus 
 Three studies have been conducted in 
which the CIDR insert was used to resynchro-
nize return to estrus in lactating dairy cows 
(Table 1). Study 1 was conducted in 2 Kansas 
herds.  The CIDR was inserted for 7 days be-
ginning at day 13 after TAI (first service, Fig-
ure 2). Cows were observed for signs of estrus 
and re-inseminated between 20 and 26 days 
after TAI. Study 2 was conducted in 7 herds 
located in 5 states. These cows were treated 
with a single injection of Lutalyse and insemi-
nated.  Beginning 14 ± days after AI, the pro-
gesterone insert was placed intravaginally for 
7 days.  Cows were observed for estrus and 
inseminated between 21 and 25 days after AI. 
Study 3 was conducted in California in 1 
commercial dairy herd.  Treatment with the 
CIDR insert occurred at 14 days after TAI 
(first service). 
 
 Results of the 3 studies are found in Table 
1. In 1 of 3 studies, conception rate of cows 
that became pregnant before treatment was 
slightly reduced, but in 2 studies, pregnancy 
loss of cows that became pregnant before 
treatment was reduced in response to the pro-
gesterone treatment during the third week of 
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pregnancy (14 ± 1 to 21 ± 1 days). Heat-
detection return rates were increased in study 
2; but overall, the percentage of cows return-
ing to estrus for re-insemination at the first 
eligible estrus did not differ from controls. 
Conception rate of the returned estrus was re-
duced in study 1, but overall, no differences 
were detected between treatments. 
 
 These studies clearly show that no harm is 
done to cows of unknown pregnancy status 
when treated with the progesterone insert 14 ± 
1 days after insemination. Return heat-
detection rates are neither improved, nor are 
return conception rates reduced. Embryo sur-
vival seemed to be improved in pregnant cows 
treated with the progesterone insert. These 
studies illustrate that 34 to 38% of cows return 
to estrus after 21 ± 1 days from previous AI. 
Emphasis on heat detection during this period 
is important to reducing inter-insemination 
intervals in cows. 
 
Use Before First Services 
 Seven studies have been conducted in 
which the progesterone insert was incorpo-
rated into the Ovsynch or Presynch + Ovsynch 
protocols for lactating dairy cows receiving 
their first AI after calving (Figure 2). Concep-
tion rates are reported for each of these studies 
in Table 2. In 4 studies in which the compari-
son was Ovsynch vs. Ovsynch + CIDR, 3 
studies (studies 1, 3, and 6) reported greater 
TAI conception rates in cows receiving pro-
gesterone. Conception rates, however, for 
older cows of study 3 and for all cows in study 
2, to which the CIDR insert was applied, were 
less than those in nontreated cows. 
 
 In 4 studies in which the comparison was 
Presynch + Ovsynch vs. Presynch + Ovsynch 
+ CIDR, positive results were reported in 2 
studies (studies 4 and 7; Table 2). For cows 
treated with the progesterone insert (studies 2 
and 5), TAI conception rates were less than in 
cows not treated. These obvious inconsisten-
cies are further compounded by the fact that in 
studies in which multiple herds were treated 
(e.g., study 6), a treatment × herd interaction 
was detected. The interaction indicates that the 
treatment (addition of progesterone) was only 
positive in some herds. 
 
 Closer examination of 2 of the studies 
cited previously (studies 6 and 7), indicates 
that progesterone is beneficial in a subpopula-
tion of all cows treated (Table 3). Based on 
blood samples collected before treatments 
were applied, the cycling status of cows in 
these 2 studies was determined. When cows 
had been exposed to elevated concentrations 
of progesterone (≥ 1 ng/mL) in either 2 or 3 
samples collected during 10 or 28 days before 
treatment, cows were classified as cycling, 
whereas those having consistently low (< 1 
ng/mL) concentrations during the same period 
were classified as noncycling. Table 3 illus-
trates these 2 classifications of cows, plus 
whether they had elevated concentrations of 
progesterone when the progesterone insert was 
removed and PGF2α was injected before TAI. 
 
 Noncycling cows having elevated proges-
terone at insert removal in study 1 were 
known to have functional luteal tissue, be-
cause the insert was removed at least 1 hour 
before blood was collected to measure proges-
terone. In study 2, blood was collected at in-
sert removal. For noncycling cows in study 1 
with elevated progesterone before PGF2α was 
injected, a follicle must have ovulated in re-
sponse to the first GnRH injection of the 
Ovsynch protocol and formed a corpus luteum 
(CL). In these cows, the CIDR insert seemed 
to provide no benefit (Table 3). In contrast, 
noncycling cows having low progesterone be-
fore PGF2α was injected remained anovulatory 
or noncycling and may have benefited from 
exposure to the insert in study 1, because TAI 
conception rates were three-fold greater than 
in no-CIDR cows (Table 3). Caution in inter-
preting a benefit is suggested because of the 
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small numbers of cows in that classification 
(noncycling + low concentrations). Further, 
this benefit was not observed for similarly 
treated cows in study 2, nor in another study 
in which TAI conception rates were 18% for 
38 CIDR-treated cows and 19% for 32 
nontreated cows. 
 
 Cycling cows having elevated concentra-
tions of progesterone before PGF2α was in-
jected were those having a functional CL at 
insert removal, whereas those having low con-
centrations at insert removal had no functional 
CL (likely regressed during progesterone 
treatment). Cycling cows, particularly those 
cows in which no functional luteal tissue was 
present at insert removal, exposed to the pro-
gesterone insert during 7 days before PGF2α 
was injected had greater TAI conception rates.  
In this case, the progesterone insert prevented 
premature estrus and ovulation. For compari-
son purposes, study 2 included cows having a 
CL at the onset of the Ovsynch protocol and 
not treated with a CIDR insert. Their TAI 
conception rates are shown in Table 3. 
 
 At present, it is difficult to make any rec-
ommendation about how the CIDR insert 
might be used to improve TAI conception 
rates in lactating dairy cows. Because of its 
cost (approximately $10), the insert should not 
be used without sound evidence for its benefit 
to fertility and a return on its investment to 
dairy producers. 
 
 One recently published study applied a 
“cherry picking” approach to use of the CIDR 
insert. This study was conducted in a dry lot 
dairy.  Cows were treated with the Presynch + 
Ovsynch protocol. Presynch PGF2α injections 
were administered at 47 and 61 days in milk 
and cows detected in estrus were inseminated 
after either Presynch injection. Heat detection 
allowed 77% (3,974 of 5,162) of the cows to 
be inseminated during 33 days that followed 
the 2 Presynch injections until Ovsynch (n = 
589) or Ovsynch + CIDR (n = 586) was ap-
plied to the remaining noninseminated cows. 
Those remaining cows exposed to the insert 
had greater TAI conception rates than 
nontreated cows (31 vs. 23%). Further, cows 
exposed to progesterone had greater concen-
trations of progesterone 14 days after TAI 
than nontreated cows, regardless of pregnancy 
status. Results of this study indicate that a 
population of cows may be responsive to the 
benefit of progesterone treatment. This popu-
lation of cows may represent a larger propor-
tion of noncycling cows and those which 
poorly express estrus. Another large-scale 
multi-herd study is currently being conducted 
to verify the results of the previous study. 
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Table 1.  Responses of Lactating Cows to CIDR Insert to Synchronize Return of Estrus 
  Previous AI Return AI 
Study Treatment 
No. of 
cows 
Conception 
rate, % 
Pregnancy 
loss, % 
No. of 
cows 
Return 
rate, % 
Conception 
rate, % 
1 
CIDR 
Control 
 
297 
327 
42 
38 
34* 
56 
169 
189 
31 
27 
20* 
32 
2 
CIDR 
Control 
 
881 
863 
33* 
37 
… 
… 
589 
544 
34* 
19 
27 
31 
3 
CIDR 
Control 
 
373 
602 
36 
32 
16* 
25 
227 
387 
55 
59 
31 
27 
Total CIDR Control 
1,551 
1,792 
35 
36 
25** 
33 
985 
1,120 
38 
34 
27 
30 
 *Differs (P < 0.05) from control within study. 
 **Differs (P < 0.05) from control across all studies. 
 
Table 2.  Synchronization of Ovulation in Lactating Dairy Cows after Ovsynch or Presynch 
+ Ovsynch Compared with Similar Treatments that Included a Progesterone Insert (CIDR) 
 Ovsynch  Presynch + Ovsynch 
Study 
Days since 
timed AI No CIDR CIDR  No CIDR CIDR 
 ---------------------------- No./no. (%) ---------------------------- 
1 291 
571 
 
33/91 (36) 
18/91 (20) 
 
54/91 (59*) 
41/91 (45*) 
    
2 291 
 
66/154 (43) 
 
48/150 (32) 
  
76/157 (48) 
 
69/153 (45) 
 
3 40 to 45 
  1st lactation 
  ≥  2nd lactation 
 
 
18/90 (20) 
44/160 (28) 
 
 
34/89 (38*) 
38/166 (22) 
    
4 40-45 
    
154/415 (37) 
 
178/414 (43*) 
 
5 27 
    
132/338 (39) 
 
121/335 (36) 
 
6 28 
56 
 
130/321 (40) 
102/321 (32) 
 
159/313 (51*) 
130/313 (42*) 
    
7 33 
61    
28/116 (24) 
24/116 (21) 
50/155 (32*) 
45/155 (29*) 
 
Totals 
 
29 to 45 291/816 (36) 335/809 (41*)  390/1,026 (38) 418/1,057 (40)
 56 to 61 120/412 (29) 171/404 (42*)  … … 
 *Differs (P < 0.05) from no-CIDR cows. 
 1Greater (P < 0.05) conception rates for Presynch cows. No effect of CIDR insert. 
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Table 3.  Pregnancy Rates at Day 56-61 After Timed Insemination According to Luteal Ac-
tivity before Treatment and Concentrations of Progesterone at the Time of PGF2α Injection 
Pretreatment 
cycling 
status1 Study 
Serum proges-
terone before 
PGF2α2 No CIDR CIDR CL present3 
   --------------- No./no. (%) --------------- 
Noncycling 1 
2 
 
High
High
Subtotal high
19/58 (33) 
8/34 (24) 
27/92 (29) 
17/47 (36) 
16/56 (29) 
33/103 (32) 
 
… 
7/25 (28) 
 
 
1 
2 
Low
Low
Subtotal low
4/38 (11) 
2/17 (12) 
6/55 (11) 
15/41 (37) 
1/30 (3) 
16/71 (23†) 
 
… 
2/12 (17) 
 Noncycling total 33/147 (22) 
 
49/174 (28)  
Cycling 1 
2 
High
High
Subtotal high
69/178 (39) 
14/54 (26) 
83/232 (36) 
79/179 (44) 
24/59 (41) 
103/238 (43†) 
 
… 
236/651 (36) 
 1 
2 
Low
Low
Subtotal low
10/47 (21) 
0/11 (0) 
10/58 (17) 
19/46 (41) 
4/10 (40) 
23/56 (41*) 
 
… 
28/108 (26) 
 Cycling total 93/290 (32) 126/294 (43*)  
*Differs (P < 0.05) from No CIDR cows. 
†Differs (P < 0.10) from No CIDR cows. 
1 Based on progesterone concentrations measured in 3 blood serum samples collected before 
each Presynch PGF2α injection and before the first GnRH injection of the Ovsynch protocol. 
2 Low = concentrations of progesterone < 1 ng/mL, and high = ≥ 1 ng/mL.  
3 Presence of a corpus luteum assessed by transrectal ultrasonography at the first GnRH in-
jection of the Ovsynch protocol. Some CIDR-treated cows may have had elevated progesterone 
because of the CIDR insert. 
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Figure 1.  Various AI Breeding Protocols for Heifers.  Option A is the labeled indication in which 
PGF2α is administered 24 hours before insert removal, and all inseminations are made after detected es-
trus. Option B tested at 3 locations included or did not include an upfront GnRH injection (CIDR insert to 
estrus in hours; CR = conception rate; PR = pregnancy rate; Total = combined pregnancy rate for CR + 
TAI). Option C tested at 12 locations includes insemination after detected estrus (CR) plus a cleanup TAI 
at 84 hours after insert removal. The last two protocols in Option C are TAI options with no heat detec-
tion.  AI = artificial insemination; TAI = timed AI; M = Monday; Tu = Tuesday; GnRH = gondadotropin 
releasing hormone; PGF2α = prostaglandin F2α; and CIDR = progesterone insert. 
AI
0           ±14             ±21
Days after TAI
Watch for estrus 
and AI
GnRH
TAI
PGF
M              M       W  Th
10−14 days
GnRH
OvsynchPresynch
PGF
14 days
PGF
CIDR
± CIDR
Use of CIDR Insert to Resynchronize Return Estrus
Use of the CIDR Insert before First AI
 
Figure 2.  Application of the Progesterone (CIDR) Insert in Lactating Dairy Cows to Resynchronize 
the Return to Estrus in Cows of Unknown Pregnancy Status or as Part of a First-service AI Breed-
ing Protocol.  AI = artificial insemination; PGF = prostaglandin F2α; GnRA = fonadotropin releasing 
hormone; TAI = timed AI; M = Monday; W = Wednesday; Th = Thursday. 
PGF2α
CIDR 
± GnRH 
PGF2α 
M                      M 
CIDR 
± GnRH 
CIDR + PGF2α 
GnRH + CIDR 
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GnRH + CIDR 
+ PGF2α 
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525                  AI at 60 hours only                    49% 
531                  TAI at 60 hours only                  53% 
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